Therapeutic Monitoring of Vancomycin in Adults
Michael J. Rybak(Eugene Applebaum College of Pharmacy and Health Sciences), Donald P. Levine(Wayne State University), William A. Craig(University of Wisconsin–Madison), J. R. Dalovisio(Ochsner Health System), Robert C. Moellering(Harvard University), John C. Rotschafer(University of Minnesota), Ben M. Lomaestro(Albany Medical Center Hospital), Marianne Billeter(University of New Orleans)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
October 26, 2009
Cited by 399
Related Papers
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
|Clinical Infectious Diseases|2011|4.2k
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
|Clinical Infectious Diseases|1998|2.9k
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
|American Journal of Health-System Pharmacy|2008|1.8k
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
|Clinical Infectious Diseases|2011|1.6k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k